Integra LifeSciences Holdings Corporation
IART
$15.10
-$0.02-0.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.89% | 8.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.89% | 8.17% | |||
| Cost of Revenue | -13.86% | 10.20% | |||
| Gross Profit | -6.82% | 6.66% | |||
| SG&A Expenses | -1.64% | 0.59% | |||
| Depreciation & Amortization | 0.21% | 1.07% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.80% | 5.15% | |||
| Operating Income | -24.61% | 35.63% | |||
| Income Before Tax | -155.89% | 163.16% | |||
| Income Tax Expenses | -63.29% | 523.52% | |||
| Earnings from Continuing Operations | -170.95% | 68.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -170.95% | 68.47% | |||
| EBIT | -24.61% | 35.63% | |||
| EBITDA | -14.39% | 18.01% | |||
| EPS Basic | -170.27% | 68.47% | |||
| Normalized Basic EPS | -17.41% | 53.44% | |||
| EPS Diluted | -160.87% | 67.33% | |||
| Normalized Diluted EPS | -17.41% | 53.44% | |||
| Average Basic Shares Outstanding | 0.23% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.23% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||